Home › Funds › First Turn Management, LLC › NAMS
First Turn Management, LLC position in NAMS
NEWAMSTERDAM PHARMA COMPANY · Health Care
First Turn Management, LLC reported holding 582,497 shares of NAMS (NEWAMSTERDAM PHARMA COMPANY) in its Q2 2026 13F filing — a position valued at US$19.7M, representing 2.11% of its reported portfolio and ranking #23 among its reported holdings. First Turn Management, LLC has disclosed NAMS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How First Turn Management, LLC's NAMS position evolved
First Turn Management, LLC first disclosed a stake in NAMS in Q2 2025 at 521,097 shares (US$9.4M). The position peaked in Q4 2025 at 893,473 shares, worth US$31.3M. Across 5 filings, First Turn Management, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 582,497 shares valued at US$19.7M — an increase of 24,161 shares quarter over quarter.. Notable position changes include a 38% increase in Q3 2025 (shares rose 23% over the following quarter), a 38% trim in Q1 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 521.10K | $9.44M | New |
| Q3 2025 | 716.97K | $20.39M | Add |
| Q4 2025 | 893.47K | $31.34M | Add |
| Q1 2026 | 558.34K | $17.87M | Reduce |
| Q2 2026 | 582.50K | $19.74M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NAMS and 13F data
NAMS (NEWAMSTERDAM PHARMA COMPANY) is a Health Care company. 43 other funds we track also report a position in NAMS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$613.0M), RA CAPITAL MANAGEMENT, L.P. (US$323.7M), FCPM III SERVICES B.V. (US$287.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NAMS
- Frazier Life Sciences Management, L.P. 18.09M sh · $613.03M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 9.55M sh · $323.66M · Q2 2026
- FCPM III SERVICES B.V. 8.49M sh · $287.74M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.26M sh · $144.53M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 3.81M sh · $129.00M · Q2 2026
- Maverick Capital 3.27M sh · $110.75M · Q2 2026
- MAVERICK CAPITAL LTD 3.27M sh · $110.75M · Q2 2026
- Duquesne Family Office LLC 3.07M sh · $104.05M · Q2 2026
- Medicxi Ventures Management (Jersey) Ltd 2.21M sh · $74.85M · Q2 2026
- Castle Hook Partners LP 1.37M sh · $46.46M · Q2 2026
- NWI MANAGEMENT LP 702.00K sh · $23.79M · Q2 2026
- Rock Springs Capital Management LP 582.74K sh · $19.75M · Q2 2026
More on First Turn Management, LLC
FAQ
How long has First Turn Management, LLC held NAMS?
First Turn Management, LLC has disclosed NAMS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is First Turn Management, LLC's current position in NAMS?
As of Q2 2026, First Turn Management, LLC holds 582.50K shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), valued at $19.74M, representing 2.11% of its reported portfolio and ranking #23.
Has First Turn Management, LLC been buying or selling NAMS?
In the latest 13F filing (Q2 2026), First Turn Management, LLC increased its position in NAMS. The position peaked in Q4 2025 at 893.47K shares.
Which other funds hold NAMS?
Other major institutional holders of NAMS include Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.